Viewing Study NCT02301234

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2026-02-21 @ 1:36 AM
Study NCT ID: NCT02301234
Status: COMPLETED
Last Update Posted: 2017-09-14
First Post: 2014-11-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Safety, Efficacy of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3007
Sponsor: Janssen Research & Development, LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Osteoarthritis View
None Pain View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Osteoarthritis View
None Pain View
None Fulranumab View
None JNJ-42160443 View
None Adjunctive therapy View
None Celecoxib View
None Hip View
None Knee View
None Joint replacement surgery View